Valuation: Biogen Inc.

Market Cap 32.66B 49,434B 28.04B 26.31B 24.03B 45.36B 3,115B 45.58B 311B 121B 1,572B 123B 120B 5,206B P/E 2026 *
39.3x
P/E 2027 * 19.4x
Enterprise Value 37.6B 56,905B 32.27B 30.29B 27.67B 52.21B 3,586B 52.46B 358B 139B 1,809B 141B 138B 5,992B EV / Sales 2026 *
3.6x
EV / Sales 2027 * 3.29x
Free-Float
85.8%
Yield 2026 *
-
Yield 2027 * -
1 day+1.41%
1 week+5.17%
Current month+10.60%
1 month+9.22%
3 months+23.54%
6 months+26.76%
Current year+31.34%
1 week 26,100
Extreme 26100
27,320
1 month 24,230
Extreme 24230
27,320
Current year 18,640
Extreme 18640
27,320
1 year 13,075
Extreme 13075
27,320
3 years 9,930
Extreme 9930
28,500
5 years 2,789.5
Extreme 2789.5
28,500
10 years 737
Extreme 737
28,500
Manager TitleAgeSince
Chief Executive Officer 66 2022-11-13
Director of Finance/CFO 60 2025-02-28
Chief Tech/Sci/R&D Officer - 2024-10-27
Director TitleAgeSince
Director/Board Member 69 2010-03-22
Director/Board Member 77 2009-12-31
Director/Board Member 72 2019-06-18
Change 5-day change 1-year change 3-year change Capi.($)
+1.41%+5.17% - - 32.62B
-2.25%-3.10%+38.65%-1.87% 83.24B
-5.77%-14.18%+505.18%+33.71% 63.41B
+0.45%+4.04%-19.50%-35.36% 59.49B
+0.76%+3.53%+0.08%+36.18% 52.94B
-1.38%+1.47%+10.64%+170.57% 49.86B
+0.14%-0.22%+61.70%-16.40% 32.62B
-1.23%-0.27%+52.52%+100.63% 26.29B
-2.55%+5.63%+17.47%+207.63% 22.23B
-1.15%-0.30%+60.29%+121.68% 17.22B
Average -0.60%+0.57%+80.78%+68.53% 45.26B
Weighted average by Cap. -0.58%-0.32%+96.85%+46.94%

Financials

2026 *2027 *
Net sales 10.44B 15,803B 8.96B 8.41B 7.68B 14.5B 996B 14.57B 99.55B 38.58B 502B 39.21B 38.36B 1,664B 10.66B 16,131B 9.15B 8.59B 7.84B 14.8B 1,017B 14.87B 102B 39.38B 513B 40.02B 39.15B 1,699B
Net income 953M 1,442B 818M 768M 701M 1.32B 90.9B 1.33B 9.09B 3.52B 45.86B 3.58B 3.5B 152B 1.9B 2,874B 1.63B 1.53B 1.4B 2.64B 181B 2.65B 18.11B 7.02B 91.39B 7.13B 6.98B 303B
Net Debt 4.94B 7,471B 4.24B 3.98B 3.63B 6.86B 471B 6.89B 47.07B 18.24B 238B 18.54B 18.13B 787B 2.42B 3,662B 2.08B 1.95B 1.78B 3.36B 231B 3.38B 23.07B 8.94B 116B 9.09B 8.89B 386B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
26-08-26 ARS 27,380.00 +0.51% 1,391
26-08-25 ARS 27,240.00 +1.41% 1,658
26-08-24 ARS 26,860.00 +1.21% 699
26-08-21 ARS 26,540.00 +1.38% 3,078
26-08-20 ARS 26,180.00 -2.60% 298
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
221.07USD
Average target price
236.22USD
Spread / Average Target
+6.85%

Quarterly revenue - Rate of surprise